153 related articles for article (PubMed ID: 21294475)
1. A renaissance in the medical treatment of advanced prostate cancer.
Rove KO; Flaig TW
Oncology (Williston Park); 2010 Dec; 24(14):1308-13, 1318. PubMed ID: 21294475
[TBL] [Abstract][Full Text] [Related]
2. US Food and Drug Administration approval of drugs for the treatment of prostate cancer: a new era has begun.
D'Amico AV
J Clin Oncol; 2014 Feb; 32(4):362-4. PubMed ID: 24344221
[No Abstract] [Full Text] [Related]
3. New prostate cancer drugs hold promise.
Cancer; 2013 Jan; 119(2):247-8. PubMed ID: 23292897
[No Abstract] [Full Text] [Related]
4. Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities.
Payne H; Bahl A; Mason M; Troup J; De Bono J
BJU Int; 2012 Sep; 110(5):658-67. PubMed ID: 22429837
[TBL] [Abstract][Full Text] [Related]
5. [Novel drugs provide better therapy for prostate cancer].
Kellokumpu-Lehtinen P; Tammela T
Duodecim; 2013; 129(9):923-30. PubMed ID: 23786104
[TBL] [Abstract][Full Text] [Related]
6. Clinical development of novel therapeutics for castration-resistant prostate cancer: historic challenges and recent successes.
Galsky MD; Small AC; Tsao CK; Oh WK
CA Cancer J Clin; 2012; 62(5):299-308. PubMed ID: 22535487
[TBL] [Abstract][Full Text] [Related]
7. [New hope in the treatment of advanced cancer of the prostate in 2012].
Massard C
Bull Cancer; 2012 Jul; 99 Suppl 1():S3. PubMed ID: 23767051
[No Abstract] [Full Text] [Related]
8. Name that prostate cancer drug.
Gomella LG
Can J Urol; 2011 Jun; 18(3):5666. PubMed ID: 21703036
[No Abstract] [Full Text] [Related]
9. New agents in the arsenal to fight castrate-resistant prostate cancer.
Ezzell EE; Chang KS; George BJ
Curr Oncol Rep; 2013 Jun; 15(3):239-48. PubMed ID: 23440553
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in pharmaceutical therapies for castration-resistant prostate cancer.
Yin L; Hu Q; Hartmann RW
Int J Mol Sci; 2013 Jul; 14(7):13958-78. PubMed ID: 23880851
[TBL] [Abstract][Full Text] [Related]
11. New treatment options for patients with metastatic castration-resistant prostate cancer.
Higano CS
Cancer Treat Rev; 2012 Aug; 38(5):340-5. PubMed ID: 21944872
[TBL] [Abstract][Full Text] [Related]
12. Novel therapies for metastatic castrate-resistant prostate cancer.
Dayyani F; Gallick GE; Logothetis CJ; Corn PG
J Natl Cancer Inst; 2011 Nov; 103(22):1665-75. PubMed ID: 21917607
[TBL] [Abstract][Full Text] [Related]
13. Contemporary management of metastatic castration-resistant prostate cancer.
Sonpavde G; Sternberg CN
Curr Opin Urol; 2011 May; 21(3):241-7. PubMed ID: 21455038
[TBL] [Abstract][Full Text] [Related]
14. Optimal management of bone metastases in prostate cancer.
Aljumaily R; Mathew P
Curr Oncol Rep; 2011 Jun; 13(3):222-30. PubMed ID: 21336561
[TBL] [Abstract][Full Text] [Related]
15. Towards random sequencing or precision medicine in castration-resistant prostate cancer?
Loriot Y; Fizazi K
Eur Urol; 2014 Jan; 65(1):37-8. PubMed ID: 24075577
[No Abstract] [Full Text] [Related]
16. [Novel agents for the therapy of castration-resistant prostate cancer: overview of pivotal studies and new strategies to come].
Ouzaid I; Ravery V; Pouessel D; Culine S
Prog Urol; 2013 Jan; 23(1):1-7. PubMed ID: 23287477
[TBL] [Abstract][Full Text] [Related]
17. Novel and bone-targeted agents for CRPC.
Fizazi K; Albiges L; Massard C; Escudier B; Loriot Y
Ann Oncol; 2012 Sep; 23 Suppl 10():x264-7. PubMed ID: 22987974
[TBL] [Abstract][Full Text] [Related]
18. [The treatment of castration-resistant prostate cancer].
Petrányi Á
Magy Onkol; 2012 Dec; 56(4):219-28. PubMed ID: 23236591
[TBL] [Abstract][Full Text] [Related]
19. Recent advances revolutionize treatment of metastatic prostate cancer.
Madan RA; Arlen PM
Future Oncol; 2013 Aug; 9(8):1133-44. PubMed ID: 23902245
[TBL] [Abstract][Full Text] [Related]
20. [How to manage patients with CRPC?].
Beuzeboc P; Massard C
Bull Cancer; 2015 Jun; 102(6):509-15. PubMed ID: 26028494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
